专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

WO2005123719A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：作为蛋白激酶抑制剂的化合物和组合物
公开(公告)号：WO2005123719A1
公开(公告)日：2005-12-29
申请号：PCT/US2005/020371
申请日：2005-06-09
申请人： IRM LLC , REN, Pingda , WANG, Xia , ZHANG, Guobao , DING, Qiang , YOU, Shuli , ZHANG, Qiong , CHOPIUK, Greg , ALBAUGH, Pamela, A. , SIM, Taebo , GRAY, Nathanael, Schiander
发明人： REN, Pingda , WANG, Xia , ZHANG, Guobao , DING, Qiang , YOU, Shuli , ZHANG, Qiong , CHOPIUK, Greg , ALBAUGH, Pamela, A. , SIM, Taebo , GRAY, Nathanael, Schiander
IPC分类号： C07D403/04
CPC分类号： C07D403/04 , C07D401/14 , C07D403/14 , C07D405/14 , C07D417/14
摘要： The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, PDGF-R, trkB, c-SRC, BMX, FGFR3, b-RAF, SGK, Tie2, Lck, JNK2 2, MKK4, c-RAF, MKK6, SAPK2 and SAPK2 kinases.
摘要翻译：本发明提供了一类新颖的化合物，包含这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调的激酶活性相关的疾病或病症的方法，特别是涉及Abl，BCR-Abl异常活化的疾病或病症，PDGF-R，trkB，c-SRC，BMX，FGFR3，b-RAF，SGK，Tie2，Lck，JNK2 2，MKK4，c-RAF，MKK6，SAPK2和SAPK2激酶。

12. 发明申请

WO2004078682A2 CYCLIC COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：作为蛋白激酶抑制剂的循环化合物和组合物
公开(公告)号：WO2004078682A2
公开(公告)日：2004-09-16
申请号：PCT/US2004/006947
申请日：2004-03-05
申请人： IRM LLC , REN, Pingda , ADRIAN, Francisco , GRAY, Nathanael S. , WANG, Xia
发明人： REN, Pingda , ADRIAN, Francisco , GRAY, Nathanael S. , WANG, Xia
IPC分类号： C07C
CPC分类号： C07D471/18 , C07D498/18 , C07D513/18
摘要： The invention provides a novel class of cyclic compounds, pharmaceutical compositions comprising such cyclic compounds and methods of using such compounds to treat or prevent diseases and disorders associated with cyclin-dependent kinases (CDKs) activity, particularly diseases associated with the activity of CDK2 and CDK5.
摘要翻译：本发明提供了一类新颖的环状化合物，包含这种环状化合物的药物组合物和使用这些化合物治疗或预防与细胞周期蛋白依赖性激酶（CDK）活性相关的疾病和病症的方法，特别是与CDK2和CDK5的活性相关的疾病。

13. 发明申请

WO2012082947A1 COMPOUNDS AND COMPOSITIONS AS TGR5 AGONISTS 审中-公开
标题翻译：化合物和组合物作为TGR5激动剂
公开(公告)号：WO2012082947A1
公开(公告)日：2012-06-21
申请号：PCT/US2011/064983
申请日：2011-12-14
申请人： IRM LLC , GAO, Wenqi , LAU, Thomas , PAN, Shifeng , PHILLIPS, Dean Paul , WANG, Xia , YANG, Yang
发明人： GAO, Wenqi , LAU, Thomas , PAN, Shifeng , PHILLIPS, Dean Paul , WANG, Xia , YANG, Yang
IPC分类号： C07D401/14 , C07D403/14 , C07D413/14 , C07D417/14 , A61K31/506 , A61K31/4155 , A61K31/4439 , A61P3/10 , A61P29/00
CPC分类号： C07D401/14 , C07D403/14 , C07D413/14 , C07D417/14
摘要： The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with TGR5.
摘要翻译：本发明提供式（I）化合物，包含这些化合物的药物组合物和使用这些化合物治疗或预防与TGR5相关的疾病或病症的方法。

14. 发明申请

WO2011097526A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：作为蛋白激酶抑制剂的化合物和组合物
公开(公告)号：WO2011097526A1
公开(公告)日：2011-08-11
申请号：PCT/US2011/023812
申请日：2011-02-04
申请人： IRM LLC , NOVARTIS AG , TELLEW, John E. , PAN, Shifeng , WAN, Yongqin , XIE, Yongping , WANG, Xing , WANG, Xia , HUANG, Shenlin , LIU, Zuosheng , ZHANG, Qiong
发明人： TELLEW, John E. , PAN, Shifeng , WAN, Yongqin , XIE, Yongping , WANG, Xing , WANG, Xia , HUANG, Shenlin , LIU, Zuosheng , ZHANG, Qiong
IPC分类号： C07D401/14 , C07D471/04 , A61K31/4353 , A61P35/00
CPC分类号： C07D471/04 , A61K31/444 , A61K31/506 , A61K31/519 , A61K45/06 , C07D401/14
摘要： The invention provides a novel class of compounds of Formula (I) (wherein A, Y, R 2 , R 3 , R 4 and R 5 are defined in the summary of the invention), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
摘要翻译：本发明提供了一类新颖的式（I）化合物（其中A，Y，R 2，R 3，R 4和R 5在本发明概述中定义），包含这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调的激酶活性相关的疾病或病症，特别是涉及B-Raf异常活化的疾病或病症。

15. 发明申请

WO2008157210A1 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS 审中-公开
标题翻译：化合物和组合物作为ITPKB抑制剂
公开(公告)号：WO2008157210A1
公开(公告)日：2008-12-24
申请号：PCT/US2008/066664
申请日：2008-06-12
申请人： IRM LLC , BURSULAYA, Badry , CHENG, Dai , JIANG, Jiqing , KARANEWSKY, Donald, S. , LIU, Yi , PAN, Shifeng , WAN, Yongqin , WANG, Xia , XIE, Yun, Feng , YANG, Yang
发明人： BURSULAYA, Badry , CHENG, Dai , JIANG, Jiqing , KARANEWSKY, Donald, S. , LIU, Yi , PAN, Shifeng , WAN, Yongqin , WANG, Xia , XIE, Yun, Feng , YANG, Yang
IPC分类号： C07D413/14 , C07D413/02 , A61K31/536 , A61P37/02
CPC分类号： C07D413/14 , C07D413/02
摘要： The invention provides a novel class of compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1, 4, 5- trisphosphate 3 -kinase B (ITPKb).
摘要翻译：本发明提供了一类新颖的式（I）化合物，包含这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调B细胞活性相关的疾病或病症的方法，特别是涉及异常活化的疾病或病症肌醇1,4,5-三磷酸3-激酶B（ITPKb）。

16. 发明申请

WO2008144253A1 PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF 审中-公开
标题翻译：蛋白激酶抑制剂及其使用方法
公开(公告)号：WO2008144253A1
公开(公告)日：2008-11-27
申请号：PCT/US2008/063187
申请日：2008-05-09
申请人： IRM LLC , REN, Pingda , WANG, Xia , JIANG, Songchun , NAGLE, Advait , OKRAM, Barun , HE, Yun , XIE, Yongping , WANG, Xing , HUANG, Shenlin , WANG, Xiaodong , LIU, Yi , ALBAUGH, Pamela, A. , GRAY, Nathanael, S. , ZHANG, Guobao
发明人： REN, Pingda , WANG, Xia , JIANG, Songchun , NAGLE, Advait , OKRAM, Barun , HE, Yun , XIE, Yongping , WANG, Xing , HUANG, Shenlin , WANG, Xiaodong , LIU, Yi , ALBAUGH, Pamela, A. , GRAY, Nathanael, S. , ZHANG, Guobao
IPC分类号： C07D471/04 , C07D487/04 , A61K31/519 , A61P35/00
CPC分类号： C07D471/04 , C07D487/04
摘要： The invention provides compounds of formula (l) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of AIk, AbI, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, BIk, Bmx, BTK, c-Kit, c-RAF, CSK, c-SRC, EphBl, EphB2, EphB4, FLTl, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFRalpha, PDGFRbeta, PKCalpha, SAPK2alpha, Src, SIK, Syk, Tie2 and TrkB kinases.
摘要翻译：本发明提供了可用作蛋白激酶抑制剂的式（I）化合物及其药物组合物，以及使用这些化合物治疗，改善或预防与异常或失调激酶活性相关的病症的方法。在一些实施方案中，本发明提供了使用这些化合物治疗，改善或预防涉及AIk，AbI，Aurora-A，B-Raf，C-Raf，Bcr-Abl，BRK，BIk等的异常活化的疾病或病症的方法。 Bcl，Bcl，BK，BK，BK，BK，BK，BKX，BTK，c-Kit，c-RAF，CSK，c-SRC，EphB1，EphB2，EphB4，FLT1，Fms，Flt3，Fyn，FRK3，JAK2，KDR，Lck，Lyn，PDGFRalpha，PDGFRbeta，PKCalpha，SAPK2alpha， Src，SIK，Syk，Tie2和TrkB激酶。

17. 发明申请

WO2007092531A3 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 审中-公开
公开(公告)号：WO2007092531A3
公开(公告)日：2007-08-16
申请号：PCT/US2007/003319
申请日：2007-02-06
申请人： IRM LLC , DING, Qiang , REN, Pingda , ZHANG, Qiong , WANG, Xia , SIM, Taebo , ALBAUGH, Pamela A. , GRAY, Nathanael S.
发明人： DING, Qiang , REN, Pingda , ZHANG, Qiong , WANG, Xia , SIM, Taebo , ALBAUGH, Pamela A. , GRAY, Nathanael S.
IPC分类号： C07D401/04 , C07D401/14 , C07D413/14 , A61K31/4427 , A61K31/444 , A61K31/4468
摘要： The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particulary diseases or disorders that involve abnormal activation of the Abl.Bcr-Abl, Bmx, b-RAF, c-RAFI c-SRC,KDR,CSKlFGFR3,JAK2ILck,Met,PKCalpha,SAPK2alpha)Tie2,TrkB and P70S6K kinases. These compounds have the following structure: (Formula I); in which: R 1 is selected from -NR 6 R 7 and -NR 6 C(O)R 8 ; wherein R 6 is selected from hydrogen and C 1-6 alkyl; R 7 is selected from hydrogen, C 1-6 alkyl. -NR 9 R 10 , C 6-10 aryl-C 0-4 alkyl, C 1-10 heteroaryl-C 0-4 alkyl, C 3-12 cycloalkyl-C 0-4 alkyl and C 3-8 heterocycloalkyl-C 0-4 alkyl; wherein any aryl, heteroaryl, cycloalkyl or heterocycloalkyl of R 7 can be optionally substituted by 1 to 3 radicals independently selected from C 1-6 alkyl, C 1-6 alkoxy, -QNR 9 R 10 and C 3-8 heterocycloalkyl-C 0-4 alkyl; wherein Q is selected from a bond and C 1-4 alkylene; R 8 is selected from hydrogen and C 1-4 alkyl; R 9 and R 10 are independently selected from hydrogen and C 1-6 alkyl; R 2 is selected from hydrogen and C 1-6 alkyl; R 3 is selected from hydrogen and C 1-6 alkyl; R 4 is selected from hydrogen, halo, C 1-6 alkyl, C 1-6 alkoxy, halosubstituted-C 1-6 alkyl and halosubsb'tuted-C 1-6 alkoxy; R 5 is selected from -C(O)NHR 11 and -NHC(O)R 11 ; wherein R 11 is selected from C 6-10 aryl and C 1-10 heteroaryl; wherein any aryl or heteroaryl of R 11 is optionally substituted with 1 to 3 radicals independently selected from halo, C 1-6 alkyl, C 1-6 alkoxy, halosubstituted-C 1-6 alkyl, halosubstituted-C 1-6 alkoxy, di-C 1-4 alkyl-amino-C 1-6 alkoxy, di-C 1-4 alkyl-amino-C 1-4 alkyl(C 1-4 alkyl)amino, C 1-10 heteroaiyl-C 0-4 alkyl, C 3-8 heterocycIoalkyl-C 0-4 alkyl and C 3-8 heterocycloalkyl-oxy; wherein any heteroaryl or heterocycloalkyl substituent of R 11 is further optionally substituted by 1 to 2 radicals independently selected from C 1-6 alkyl and hydroxy-C 1-6 alkyl; X and Y are independently selected from N and CH; and the pharmaceutically acceptable salts, hydrates, solvates and isomers thereof.

18. 发明申请

WO2006101783A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS 审中-公开
标题翻译：作为蛋白激酶抑制剂的化合物和组合物
公开(公告)号：WO2006101783A2
公开(公告)日：2006-09-28
申请号：PCT/US2006/008719
申请日：2006-03-10
申请人： IRM LLC , REN, Pingda , GRAY, Nathanael, S. , WANG, Xia , ZHANG, Gubao
发明人： REN, Pingda , GRAY, Nathanael, S. , WANG, Xia , ZHANG, Gubao
IPC分类号： A61K31/519
CPC分类号： C07D487/04 , A61K31/519 , A61K31/52
摘要： The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, BMX, BTK, CHK2, c-RAF, CSK, c-SRC, Fes, FGFR3, Flt3, IKKα , IKKβ, JNK2α 2, Lck, Met, MKK4, MKK6, MST2, NEK2, p70S6K, PDGFRβ , PKA, PKB β, PKD2, Rsk1, SAPK2α , SAPK2β , SAPK3, SGK, Tie2 and TrkB kinases.
摘要翻译：本发明提供了一类新颖的化合物，包含这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调的激酶活性相关的疾病或病症的方法，特别是涉及Abl，Bcr-Abl异常活化的疾病或病症，BMX，BTK，CHK2，c-RAF，CSK，c-SRC，Fes，FGFR3，Flt3，IKKa，IKKβ，JNK2a2，Lck，Met，MKK4，MKK6，MST2，NEK2，p70S6K，PDGFRβ，PKA，PKB ，PKD2，Rsk1，SAPK2a，SAPK2β，SAPK3，SGK，Tie2和TrkB激酶。

19. 发明申请

WO2008011611A3 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS 审中-公开
公开(公告)号：WO2008011611A3
公开(公告)日：2008-01-24
申请号：PCT/US2007/074048
申请日：2007-07-20
申请人： IRM LLC , PAN, Shifeng , LIU, Yi , XIE, Yun Feng , CHENG, Dai , WAN, Yongqin , HAN, Dong , YANG, Yang , GAO, Wenqi , JIANG, Jiqing , BURSULAYA, Badry , CHAMBERLAIN, Philip , KARANEWSKY, Donald S. , WANG, Xia
发明人： PAN, Shifeng , LIU, Yi , XIE, Yun Feng , CHENG, Dai , WAN, Yongqin , HAN, Dong , YANG, Yang , GAO, Wenqi , JIANG, Jiqing , BURSULAYA, Badry , CHAMBERLAIN, Philip , KARANEWSKY, Donald S. , WANG, Xia
IPC分类号： C07D231/12 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/14 , C07D491/048 , A61K31/415 , A61K31/44 , A61P17/00 , A61P19/02
摘要： The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1, 4, 5-trisphosphate 3-kinase B (ITPKb).

20. 发明申请

WO2008008747A1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS 审中-公开
标题翻译： [4,5']作为蛋白激酶抑制剂的双嘧啶-6,17-二胺衍生物
公开(公告)号：WO2008008747A1
公开(公告)日：2008-01-17
申请号：PCT/US2007/073111
申请日：2007-07-10
申请人： IRM LLC , ALBAUGH, Pamela A. , HE, Yun , JIANG, Songchun , REN, Pingda , WANG, Xia , WANG, Xing , XIE, Yongping
发明人： ALBAUGH, Pamela A. , HE, Yun , JIANG, Songchun , REN, Pingda , WANG, Xia , WANG, Xing , XIE, Yongping
IPC分类号： C07D239/42 , C07D401/12 , C07D401/14 , A61K31/506 , A61P35/00
CPC分类号： C07D401/14 , C07D239/42 , C07D401/12
摘要： The invention provides a novel class of compounds of the Formula (I): in which the symbols have the meanings given in the description and claims, to pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of FGFR3 kinase.
摘要翻译：本发明提供了一类新颖的式（I）化合物：其中符号具有在说明书和权利要求书中给出的含义，涉及包含这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调的激酶活性，特别是涉及FGFR3激酶异常激活的疾病或病症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式